- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06230939
Examination of Factors Associated With Fatigue in Individuals Diagnosed With Parkinson's Disease
January 29, 2024 updated by: Asli Celik, Nigde Omer Halisdemir University
Fatigue is defined as an overwhelming feeling of weariness, lack of energy, and a feeling of exhaustion.
It is common in Parkinson's Disease (PD) and is one of the most disabling symptoms.
Fatigue is affected by motor and non-motor symptoms in individuals diagnosed with PD.
As a result of this impact, it manifests itself as difficulty in initiating and continuing mental and physical tasks.
This study aims to examine the fatigue of individuals diagnosed with PD and the factors associated with this fatigue.
Study Overview
Detailed Description
The study will be carried out in cooperation with Gazi University Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation and Nigde Omer Halisdemir University, and the study data will be collected from individuals diagnosed with PD who applied to the Neurology Polyclinic of Nigde Omer Halisdemir University Training and Research Hospital.
Necessary permissions have been obtained from all institutions.
Modified Hoehn&Yahr staging (HYS) and Unified Parkinson's Disease Rating Scale (UPDRS and its subtests) will be used for disease staging and grading.
Parkinson's Fatigue Scale-16 (PFS-16) to evaluate fatigue, Parkinson's Disease Sleep Scale-2 (PDSS-2) to evaluate sleep, Hospital Anxiety and Depression Scale (HAD) to evaluate depression and anxiety, Mini-Mental to evaluate cognitive status (MMSE) will be used.
In addition, "Timed Up and Go (TUG)" will be applied for lower extremity performance evaluation.
All evaluations will be collected in a single meeting using the face-to-face interview method.
It is calculated that 80% power will be reached with a margin of error of 0.05 when 84 individuals diagnosed with PD are included in the study.
Study Type
Observational
Enrollment (Estimated)
84
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aslı ÇELİK, MSc.
- Phone Number: 2093 +90388 311 21 05
- Email: fztaslicelik@gmail.com
Study Locations
-
-
-
Ankara, Turkey, 06490
- Recruiting
- Gazi University
-
Principal Investigator:
- İlke KESER, Prof. Dr.
-
Nigde, Turkey, 51200
- Recruiting
- Nigde Omer Halisdemir University
-
Sub-Investigator:
- Gürkan DEMİRTAŞ, MSc.
-
Principal Investigator:
- Aslı ÇELİK, MSc.
-
Sub-Investigator:
- Dilek İŞCAN, Assist. Prof
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The research will be carried out in cooperation with Gazi University Faculty of Health Sciences and Nigde Omer Halisdemir University.
Study data will be obtained from individuals diagnosed with PD who apply to Nigde Omer Halisdemir University Training and Research Hospital Neurology Polyclinic.
Necessary permissions were obtained from all institutions.
Description
Inclusion Criteria:
- Being 18 years or older,
- Being diagnosed with PD by a neurologist,
- Having stable medical treatment,
- Being able to stand independently for at least 60 seconds without any assistive device,
- Having received 18 points or more according to the MMSD evaluation.
Exclusion Criteria:
- Being illiterate or unable to communicate in Turkish,
- Having undergone a surgery that may affect lower extremity functions,
- Diabetes mellitus is a diagnosis of another neurological and rheumatic disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Parkinson's Disease Group
The study will be conducted in collaboration with Gazi University Faculty of Health Sciences and Nigde Omer Halisdemir University.
The study data will be obtained from individuals diagnosed with PD admitted to the Neurology Outpatient Clinic of Nigde Omer Halisdemir University Training and Research Hospital.
Necessary permissions were obtained from all institutions.
All evaluations will be collected in a single meeting using the face-to-face interview method.
It is calculated that 80% power will be reached with a margin of error of 0.05 when 84 individuals diagnosed with PD are included in the study.
|
Individual characteristics of the patients (gender, age, height, body weight, marital status, education level, dominant extremity, smoking and alcohol consumption habits, use and type of assistive device, how many years the assistive device has been used) and disease-related (year of diagnosis, disease duration Information (such as CV, family history, medications used, surgeries) will be questioned.
HYE and UPDRS will be used for disease staging and grading.
PFS-16 will be used to evaluate fatigue and MMSE will be used to evaluate sleep.
In addition, "Timed Up and Go (TUG)" will be applied for lower extremity performance evaluation.
All evaluations will be collected in a single meeting using the face-to-face interview method.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parkinson Fatigue Scale-16 (PFS-16);
Time Frame: Baseline
|
PFS-16, consists of 16 items designed to evaluate the impact of fatigue on daily life and its physical dimensions.
The scale allows measuring the presence of fatigue (7 items) and its impact on daily function (9 items).
Individuals are asked to respond to statements about fatigue on a 5-point Likert scale between 1 (strongly disagree) and 5 (strongly agree).
|
Baseline
|
Hospital Anxiety and Depression Survey (HAD)
Time Frame: Baseline
|
Each item of the scale, which consists of 14 items, is scored between 0 and 3.
For anxiety and depression values, 0-7 points are considered normal, 8-10 points are considered borderline, and 11 points and above are considered abnormal.
The validity and reliability of this scale in Turkish has been established.
|
Baseline
|
Parkinson's Disease Sleep Scale-2 (PDSS-2)
Time Frame: Baseline
|
The scale is a 5-point Likert type (4: Very often, 6-7 days a week; 3: Frequently, 4-5 days a week; 2: Sometimes, 2-3 days a week; 1: Occasionally, 1 day a week; 0: Never) consists of 15 items.
The scale includes general night sleep quality (item 1), falling asleep (item 2), insomnia (item 3), night restlessness (items 4 and 5), night psychosis (items 6 and 7), nocturia (item 8). .
and items 9), night motor symptoms (items 10, 11, 12 and 13), waking up rested (item 14) and sleep-disordered breathing (item 15) are evaluated.
|
Baseline
|
Time Up and Go Test (TUG)
Time Frame: Baseline
|
Timed get up and go test is used for functional evaluation of patients.
This test is important in terms of evaluating patients' walking speed as well as testing their ability to maintain balance.
In the test application, after the patient gets up from the chair without back support, he walks three meters to the marked area, turns back, and on the way back, the time to sit on the chair is calculated by walking three meters again.
The test is repeated three times and the average in seconds is recorded.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mini Mental State Examination (MMSE)
Time Frame: Baseline
|
MMSE will be used to evaluate cognitive functions.
The mini mental test is categorized under five main headings.
It consists of 11 items including orientation (10 points), recording memory (3 points), attention and calculation (5 points), recall (3 points) and language (9 points).
It is evaluated over 30 points in total.
A score between 24-30 points is defined as normal, 18-23 points as mild dementia, and 17 points and below as severe dementia.
The average administration time of the test is 10 minutes.
Patients scoring 18 and above will be included in the study.
|
Baseline
|
Unified Parkinson's Disease Rating Scale (UPDRS)
Time Frame: Baseline
|
Unified Parkinson's Disease Rating Scale (UPDRS) is a scale created to evaluate the motor performance, mental and spiritual status, and daily life activities of patients diagnosed with PD.
The scale consists of a total of 4 sections and 42 items.
In the first part, non-motor symptoms such as thoughts, behavior and affect; In the second part, activities of daily living; motor symptoms in the third part; In the fourth section, treatment complications are evaluated.
Each item is scored between 0 (no symptoms or signs) and 4 (the most severe symptom or sign possible).
|
Baseline
|
Modified Hoehn-Yahr Evaluation (MHYE)
Time Frame: Baseline
|
Modified Hoehn-Yahr Evaluation (MHYE) used to define the disease stage of patients diagnosed with PD.
According to MHYE, the disease consists of 8 stages.
It is stated that the disease symptoms worsen as the stage progresses.
|
Baseline
|
Interview Form
Time Frame: Baseline
|
All evaluations will be carried out by face-to-face interview method.
Individual characteristics of the patients (gender, age, height, body weight, marital status, education level, dominant extremity, smoking and alcohol consumption habits, use and type of assistive device, how many years the assistive device has been used) and disease-related (year of diagnosis, disease duration Information (such as CV, family history, medications used, surgeries) will be questioned.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: İlke KESER, Prof. Dr., Gazi University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Opara J, Malecki A, Malecka E, Socha T. Motor assessment in Parkinson;s disease. Ann Agric Environ Med. 2017 Sep 21;24(3):411-415. doi: 10.5604/12321966.1232774. Epub 2017 May 11.
- Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 2016 Nov;15(12):1257-1272. doi: 10.1016/S1474-4422(16)30230-7. Epub 2016 Oct 11.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 5, 2023
Primary Completion (Estimated)
November 5, 2025
Study Completion (Estimated)
November 5, 2025
Study Registration Dates
First Submitted
January 19, 2024
First Submitted That Met QC Criteria
January 29, 2024
First Posted (Actual)
January 30, 2024
Study Record Updates
Last Update Posted (Actual)
January 30, 2024
Last Update Submitted That Met QC Criteria
January 29, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Gazi University-05.09.2023.3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fatigue
-
Bakulev Scientific Center of Cardiovascular SurgeryFoundation for the Support of Physical Culture and Sports BECOME A CHAMPION; Autonomous Non-Profit organization of additional education sports school BECOME A CHAMPIONNot yet recruitingEfficacy, Self | Fatigue, Mental | Fatigue; Muscle, Heart | Fatigue; CombatRussian Federation
-
Universita di VeronaUniversity of Southern CaliforniaCompletedDiet, Healthy | Fasting | Fatigue, Mental | Fatigue; Muscle, HeartItaly
-
University of ZurichRecruitingVocal FatigueSwitzerland
-
KU LeuvenCompleted
-
Société des Produits Nestlé (SPN)Maastricht University Medical CenterCompleted
-
University of Applied Sciences for Health Professions...University of Wisconsin, MilwaukeeCompleted
-
Taoyuan General HospitalCompleted
-
Alaa Yousri Mahmoud AtiaUnknownMuscle FatigueEgypt
-
University Hospital, Clermont-FerrandLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques...CompletedNeuromuscular FatigueFrance
-
Central Hospital, Nancy, FranceUniversity of Lorraine; Institut National de Recherche et de Sécurité, Nancy...Unknown
Clinical Trials on Examination
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityThe First Affiliated Hospital of Guangzhou Medical UniversityNot yet recruitingArtificial Intelligence | Pulmonary Diseases | Ophthalmological Diagnostic TechniquesChina
-
Vanderbilt University Medical CenterAllerganCompletedNervous System Diseases | Neurologic Manifestations | Muscular Diseases | Neuromuscular Manifestations | Muscle Hypertonia | Spasticity, Muscle | Muscle Spasticity | Musculoskeletal Disease | Signs and SymptomsUnited States
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Adiyaman University Research HospitalNot yet recruitingPostdural Puncture HeadacheTurkey
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingDiabetic Retinopathy
-
Brugmann University HospitalCompletedFetal MacrosomiaBelgium
-
University Hospital, Basel, SwitzerlandDePuy SynthesRecruitingArthroscopic Rotator Cuff Repair (ARCR)Switzerland
-
Shin Kong Wu Ho-Su Memorial HospitalCompleted
-
Umeå UniversityCompleted